Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Doxycycline
Vetpharma Animal Health, S.L.
QJ01AA02
Doxycycline
500 milligram(s)/gram
Powder for use in drinking water
POM: Prescription Only Medicine as defined in relevant national legislation
Chickens, Pigs, Turkeys
doxycycline
Antibacterial
Authorised
2013-01-25
Health Products Regulatory Authority 27 October 2017 CRN000VG0 Page 1 of 8 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Powdox Doxycycline 500 mg/g powder for use in drinking water for pigs, chickens and turkeys 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each g contains: ACTIVE SUBSTANCE: Doxycycline 500.0 mg (equivalent to doxycycline hyclate 580.0 mg) Excipients: For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Powder for use in drinking water. Yellowish powder. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs for fattening, chickens (broilers, chicken for reproduction) and turkeys (broilers, turkeys for reproduction). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: treatment of clinical respiratory infections caused by _Mycoplasma _ _hyopneumoniae _and _Pasteurella multocida _strains susceptible to doxycycline. Chickens and turkeys: treatment of clinical respiratory infections associated with _Mycoplasma gallisepticum _susceptible to doxycycline. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any excipient. Do not use in animals with hepatic dysfunction. Health Products Regulatory Authority 27 October 2017 CRN000VG0 Page 2 of 8 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of drinking water, animals should be treated parenterally. Under-dosing and/or treating for an insufficient length of time are considered to promote the development of resistance in bacteria and should be avoided. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Inappropriate use of the product may increase the prevalence of bacteria resistant to tetracycline due to the potential for cross resistance. Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological Preberite celoten dokument